Talk:Enzyme potentiated desensitization: Difference between revisions
Technopete (talk | contribs) No edit summary |
Technopete (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
Aperson - most of your edits are most welcome, particularly changing the refs (I'm new to this game), but the fact was that EPD was only allowed by the FDA to be imported into the USA because of an investigative study authorised by the FDA. When the FDA revoked approval for it then EPD could no longer be imported. The reasons given by the FDA were that each EPD treatment used a number of mixed allergens for each medicine, and the FDA's reading of its own rules was that this was not permitted. There is no pending investigative study by the FDA. My understanding is that they will only let EPD back into the USA if it gets a marketing license, and that this would have to be for each allergen separately, which would cost a fortune (tens of millions of dollars) and never be affordable. So I will change that bit of your edit.[[User:Technopete|Peter Davies]] 22:31, 15 September 2006 (UTC) |
|||
⚫ | |||
⚫ | |||
Could the author please use [[Wikipedia:Footnotes]] to string references to the claims made in this article? [[User:Jfdwolff|JFW]] | [[User_talk:Jfdwolff|<small>T@lk</small>]] 11:00, 14 September 2006 (UTC) |
Could the author please use [[Wikipedia:Footnotes]] to string references to the claims made in this article? [[User:Jfdwolff|JFW]] | [[User_talk:Jfdwolff|<small>T@lk</small>]] 11:00, 14 September 2006 (UTC) |
Revision as of 10:41, 17 September 2006
Aperson - most of your edits are most welcome, particularly changing the refs (I'm new to this game), but the fact was that EPD was only allowed by the FDA to be imported into the USA because of an investigative study authorised by the FDA. When the FDA revoked approval for it then EPD could no longer be imported. The reasons given by the FDA were that each EPD treatment used a number of mixed allergens for each medicine, and the FDA's reading of its own rules was that this was not permitted. There is no pending investigative study by the FDA. My understanding is that they will only let EPD back into the USA if it gets a marketing license, and that this would have to be for each allergen separately, which would cost a fortune (tens of millions of dollars) and never be affordable. So I will change that bit of your edit.Peter Davies 22:31, 15 September 2006 (UTC)
Changed to footnotes as suggested by Jfdwolff Peter Davies 22:31, 15 September 2006 (UTC)
Could the author please use Wikipedia:Footnotes to string references to the claims made in this article? JFW | T@lk 11:00, 14 September 2006 (UTC)